JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amano, M.
Right arrow Articles by Kaibuchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amano, M.
Right arrow Articles by Kaibuchi, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 34, Issue of August 23, 1996 pp. 20246-20249
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

COMMUNICATION:
Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)*

(Received for publication, May 15, 1996, and in revised form, June 19, 1996)

Mutsuki Amano , Masaaki Ito Dagger , Kazushi Kimura §, Yuko Fukata , Kazuyasu Chihara , Takeshi Nakano Dagger , Yoshiharu Matsuura and Kozo Kaibuchi par

From the Division of Signal Transduction, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-01, the Dagger  First Department of Internal Medicine, Mie University School of Medicine, Tsu 514, the § Second Department of Anatomy, Kyoto University Faculty of Medicine, Kyoto 606, and the  Department of Virology II, National Institute of Health, Tokyo 162, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The small GTPase Rho is implicated in physiological functions associated with actin-myosin filaments such as cytokinesis, cell motility, and smooth muscle contraction. We have recently identified and molecularly cloned Rho-associated serine/threonine kinase (Rho-kinase), which is activated by GTP·Rho (Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) EMBO J. 15, 2208-2216). Here we found that Rho-kinase stoichiometrically phosphorylated myosin light chain (MLC). Peptide mapping and phosphoamino acid analyses revealed that the primary phosphorylation site of MLC by Rho-kinase was Ser-19, which is the site phosphorylated by MLC kinase. Rho-kinase phosphorylated recombinant MLC, whereas it failed to phosphorylate recombinant MLC, which contained Ala substituted for both Thr-18 and Ser-19. We also found that the phosphorylation of MLC by Rho-kinase resulted in the facilitation of the actin activation of myosin ATPase. Thus, it is likely that once Rho is activated, then it can interact with Rho-kinase and activate it. The activated Rho-kinase subsequently phosphorylates MLC. This may partly account for the mechanism by which Rho regulates cytokinesis, cell motility, or smooth muscle contraction.


INTRODUCTION

Rho is a small GTPase, which exhibits both GDP/GTP binding and GTPase activities (for reviews, see Refs. 1 and 2). Rho has GDP-bound inactive and GTP-bound active forms, which are interconvertible by GDP/GTP exchange and GTPase reactions (1, 2). Rho is implicated in the cytoskeletal responses to extracellular signals including lysophosphatidic acid and certain growth factors, which form stress fibers and cause focal adhesion (3, 4). Rho is also implicated in other physiological functions associated with cytoskeletal rearrangements such as cell morphology (5), cell aggregation (6), cell motility (7), and cytokinesis (8, 9). Recent studies indicate that Rho is also involved in the regulation of phosphatidylinositol 3-kinase (10, 11, 12), phosphatidylinositol 4-phosphate-5-kinase (13), and c-fos expression (14). Upon stimulation with certain extracellular signals, GDP·Rho may be converted to GTP·Rho, and then it can bind to specific targets and cause its effects. We have recently purified three putative targets for Rho (p128, p138, and p164) from the bovine brain (15, 16). p128 was identified as serine/threonine kinase, protein kinase N (15). p138 was identified as the MBS1 of myosin phosphatase (16). p164 was identified as a novel serine/threonine kinase, named Rho-kinase (17), which is also known as ROK (18).

MLC phosphorylation plays pivotal roles in smooth muscle contraction (for reviews, see Refs. 19, 20, 21) and in the actin-myosin interaction for stress fiber and contractile ring formation in non-muscle cells (for a review, see Ref. 22). This also has an effect on cytokinesis and cell motility (22). MLC kinase primarily phosphorylates MLC at Ser-19 (19, 20, 21, 23). Any protein kinases so far obtained, besides specific kinases such as MLC kinase, do not phosphorylate this site (24). When smooth muscles are stimulated by agonists such as vasoconstrictors, Ca2+ is mobilized into the cytoplasm. Ca2+ activates the calmodulin-dependent MLC kinase. The MLC phosphorylation induces myosin-actin interaction and thereby activates myosin ATPase (19, 20, 21), which then induces smooth muscle contraction (19, 20, 21). However, the cytosolic Ca2+ level is not always proportional to the contraction level, and an additional mechanism that can regulate the Ca2+ sensitivity of the smooth muscle contraction has been proposed (25). Since GTPgamma S, a non-hydrolyzable GTP analog, lowers the Ca2+ concentrations necessary for the contraction of permeabilized smooth muscles, a GTP-binding protein was presumed to regulate the Ca2+ sensitivity (26, 27). Rho has been shown to be involved in the GTP-enhanced Ca2+ sensitivity of the smooth muscle contraction (28). Recent evidence suggests that GTPgamma S increases MLC phosphorylation at submaximal Ca2+ concentrations presumably by inhibiting myosin phosphatase through Rho (29). We have recently shown that GTP·Rho activates Rho-kinase, and then Rho-kinase phosphorylates MBS and thereby inactivates myosin phosphatase (16). This may increase MLC phosphorylation and induce the consequent contraction of the smooth muscles.

To extend these observations, we have examined if Rho-kinase phosphorylates MLC. We found that Rho-kinase stoichiometrically phosphorylated MLC at the site that is phosphorylated by MLC kinase, which causes the activation of myosin ATPase.


EXPERIMENTAL PROCEDURES

Materials and Chemicals

MLC (30), Myosin and MLC kinase (23) were purified from the frozen chicken gizzard. F-actin was purified from the rabbit skeletal muscle (31). Rho-kinase was purified from the bovine brain (17). [gamma -32P]ATP was purchased from Amersham Corp. All materials used in the nucleic acid study were purchased from Takara Shuzo Co., Ltd. (Kyoto, Japan). Other materials and chemicals were obtained from commercial sources.

Preparation of GST-Rho-kinase, GST-MLC, and GST-MLCA18A19

The cDNA encoding the catalytic fragment of Rho-kinase (6-553 amino acids) was inserted into the BamHI site of pAcYM1-GST to produce GST-Rho-kinase. GST-Rho-kinase was purified from Sf9 cells by use of a baculovirus system (32) by means of a glutathione-Sepharose column (17). GST-Rho-kinase was constitutively active.2 The cDNA fragment encoding MLC was amplified by polymerase chain reaction from rat brain Quick clone cDNA (Clontech) with the primers 5'-AATAGGATCCGATTTAACCGCCACCATGTCG-3' and 5'-ATAAGGATCCTCAGTCATCTTTGTCTTTCGCTC-3'. Substitution of alanine residues for threonine 18 and serine 19 was performed by polymerase chain reaction. The cDNA fragments were cloned into the BamHI site of pGEX-2T. GST-MLC and GST-MLCA18A19 were purified as described (17).

Phosphorylation Assay

The kinase reaction for Rho-kinase was carried out in 50 µl of the reaction mixture (50 mM Tris/HCl at pH 7.5, 2 mM EDTA, 1 mM DTT, 7 mM MgCl2, 0.15% CHAPS, 250 µM [gamma -32P]ATP (1-20 GBq/mmol), purified enzyme, and indicated amounts of MLC or myosin) with or without 1 µM GTPgamma S·GST-RhoA. The kinase reaction for MLC kinase was carried out in 50 µl of the reaction mixture (50 mM Tris/HCl at pH 7.5, 1 mM MgCl2, 85 mM KCl, 250 µM [gamma -32P]ATP (0.5-5 GBq/mmol), purified enzyme, and indicated amounts of MLC or myosin) with or without 0.1 mM CaCl2 and 10 µg/ml calmodulin. After an incubation for 10 min at 30 °C, the reaction mixtures were boiled in SDS-sample buffer and subjected to SDS-PAGE. The radiolabeled bands were visualized by an image analyzer (Fuji).

Myosin ATPase Assay

Myosin ATPase assay was carried out as described (33) with minor modifications. Briefly, 0.1 mg/ml myosin was phosphorylated by GST-Rho-kinase (4.5 µg of protein) in 0.45 ml of the reaction mixture (50 mM Tris/HCl at pH 7.5, 1 mM DTT, 5 mM MgCl2, 1 mM EGTA, 85 mM KCl, and 500 µM ATP (80-200 MBq/mmol)) for 20 min at 30 °C. Myosin was phosphorylated by MLC kinase (4.5 µg of protein) under similar conditions except in the presence of 0.1 mM CaCl2 and 10 µg/ml calmodulin. The myosin ATPase reaction was carried out in 0.1 ml of ATPase buffer (0.05 mg/ml phosphorylated myosin, 50 mM Tris/HCl at pH 7.5, 0.5 mM DTT, 10 mM MgCl2, 0.5 mM EGTA, 85 mM KCl, and 1 mM ATP (80-200 MBq/mmol)) at the indicated concentrations of F-actin for 30 min at 30 °C. An aliquot (80 µl) of the reaction mixture was added into the stop solution (1.3% charcoal, 0.12 M NaH2PO4, and 0.33 M perchloric acid) and filtrated. Inorganic phosphate that was liberated from [gamma -32P]ATP was assessed by a scintillation counter.

Other Procedures

SDS-PAGE was performed as described previously (34). A phosphopeptide mapping analysis of MLC was carried out as described (35). A phosphoamino acid analysis of MLC was carried out as described (36).


RESULTS

We examined whether Rho-kinase phosphorylates isolated MLC in a cell-free system and found that Rho-kinase phosphorylated MLC (Fig. 1A). GTPgamma S·GST-RhoA enhanced the phosphorylation of MLC by Rho-kinase, but GDP·GST-RhoA or GTPgamma S·GST-RhoAA37 did not (Fig. 1A). RhoA37 is structurally equivalent to RasA35, which contains an amino acid substitution in the effector domain that causes it to fail to interact with its target (37, 38). GTPgamma S·GST-Rac1 had no effect. The recombinant Rho-kinase (GST-Rho-kinase), which is constitutively active, phosphorylated MLC. Under similar conditions, MLC kinase phosphorylated MLC in a Ca2+-calmodulin-dependent manner (Fig. 1A). We also found that Rho-kinase phosphorylated the MLC of intact myosin in a GTPgamma S·GST-RhoA-dependent manner (Fig. 1A).


Fig. 1. Phosphorylation of MLC by Rho-kinase. A, isolated MLC (0.5 µg of protein) was phosphorylated by Rho-kinase (20 ng of protein) in the presence of either GST (lane 1), GDP·GST-RhoA (lane 2), GTPgamma S·GST-RhoA (lane 3), GTPgamma S·GST-RhoAA37 (lane 4), GDP·GST-Rac1 (lane 5), or GTPgamma S·GST-Rac1 (lane 6), by GST-Rho-kinase (5 ng of protein) (lane 7), or by MLC kinase (10 ng of protein) in the absence (lane 8) or presence (lane 9) of Ca2+ and calmodulin. Intact myosin (5 µg of protein) was phosphorylated by Rho-kinase in the absence (lane 10) or presence (lane 11) of GTPgamma S·GST-RhoA. The phosphorylated MLC was resolved by a SDS-PAGE and visualized by an image analyzer. The results are representative of three independent experiments. B, various doses of MLC were phosphorylated by Rho-kinase (25 ng of protein) in the absence (open circle ) or presence (bullet ) of GTPgamma S·GST-RhoA, by GST-Rho-kinase (7.5 ng of protein) (black-triangle), or by MLC kinase (7.5 ng of protein) in the absence (square ) or presence (black-square) of Ca2+ and calmodulin. The values shown are means ± S.E. of triplicates.
[View Larger Version of this Image (29K GIF file)]

About 1 mol of phosphate could be maximally incorporated into 1 mol of isolated MLC or MLC of intact myosin by Rho-kinase in the presence of GTPgamma S·GST-RhoA and by GST-Rho-kinase (data not shown). It is noted that a limited number of kinases such as MLC kinase and protein kinase C are known to phosphorylate intact myosin stoichiometrically (24).

The apparent affinity of isolated MLC for Rho-kinase was estimated by measuring the phosphorylation of various concentrations of MLC (Fig. 1B). The apparent Km values for MLC in the presence and absence of GTPgamma S·GST-RhoA were 2.6 ± 0.4 and 12.6 ± 1.6 µM, and the molecular activities were 0.26 ± 0.03 and 0.15 ± 0.02 s-1, respectively. Thus, it is likely that GTPgamma S·GST-RhoA increases the affinity of Rho-kinase for MLC and produces the maximum velocity of the phosphorylation reaction. The apparent Km value and molecular activity of GST-Rho-kinase were 0.91 ± 0.07 µM and 0.67 ± 0.09 s-1, respectively. The apparent Km value and molecular activity of MLC kinase for MLC were 52.1 ± 7.1 µM and 2.0 ± 0.36 s-1, respectively, under the conditions. The Km value of Rho-kinase for MLC was lower than that of MLC kinase, indicating that Rho-kinase phosphorylates myosin at lower concentrations, but the molecular activity of Rho-kinase was lower than that of MLC kinase. The lower molecular activity of Rho-kinase than that of GST-Rho-kinase may be explained by the fact that Rho-kinase lost its activity to some extent during the purification.

MLC is phosphorylated primarily at Ser-19 and secondarily at Thr-18 by MLC kinase (23), and the phosphorylation of Ser-19 is essential to facilitate actin activation of myosin ATPase (39, 40). MLC is phosphorylated at Ser-1, Ser-2, and Thr-9 by protein kinase C, and this phosphorylation by protein kinase C inhibits the actin activation of myosin ATPase (41, 42, 43). To determine the primary phosphorylation site of MLC by Rho-kinase, we performed peptide mapping of the phosphorylated MLC by either Rho-kinase, MLC kinase, or protein kinase C in vitro. The pattern of two-dimensional peptide mapping of MLC phosphorylated by Rho-kinase was identical to that produced by MLC kinase and different from that produced by protein kinase C (Fig. 2A). A phosphoamino acid analysis revealed that phosphorylation occurred mainly on the serine residue and partially on the threonine residue of the MLC that was phosphorylated by Rho-kinase and that the phosphorylation occurred only on the serine residue of the MLC that was phosphorylated by the MLC kinase. It may be noted that the MLC kinase preferentially phosphorylates MLC at Ser-19 in these conditions. Essentially identical results were obtained when GST-Rho-kinase was used instead of Rho-kinase.


Fig. 2. Identification of the phosphorylation site of MLC by Rho-kinase. A, a phosphopeptide mapping analysis of MLC. MLC (0.5 µg of protein) was phosphorylated by Rho-kinase, MLC kinase, or protein kinase C. Phosphorylated MLC was digested with trypsin, and each sample was loaded onto a silica gel plate. Phosphopeptides were separated by electrophoresis (horizontal dimension) and chromatography (vertical dimension) and then were visualized by an image analyzer. Asterisks denote origins. B, phosphorylation of recombinant MLC. MLC, GST, GST-MLC, or GST-MLCA18A19 (2 µM each) was phosphorylated by Rho-kinase (20 ng of protein), GST-Rho-kinase (10 ng of protein), or MLC kinase (10 ng of protein) as indicated. Lanes 1-4, by Rho-kinase; lanes 5-8, by GST-Rho-kinase; lanes 9-12, by MLC kinase. Lanes 1, 5, and 9, MLC; lanes 2, 6, and 10, GST; lanes 3, 7, and 11, GST-MLC; lanes 4, 8, and 12, GST-MLCA18A19. The results are representative of three independent experiments.
[View Larger Version of this Image (39K GIF file)]

We fused GST proteins with wild type MLC and with MLC containing a substitution for the alanine residues for Thr-18 and Ser-19, and then we examined if Rho-kinase and MLC kinase could phosphorylate these recombinant proteins. Rho-kinase, GST-Rho-kinase, and MLC kinase phosphorylated GST-MLC but did not phosphorylate GST or GST-MLCA18A19 (Fig. 2B). Protein kinase C phosphorylated both GST-MLC and GST-MLCA18A19 (data not shown). These results indicate that Rho-kinase phosphorylates MLC mainly at Ser-19, which is the same site phosphorylated by MLC kinase.

To examine whether Rho-kinase functions equivalently to MLC kinase in a cell-free system, we performed the actin-activated MgATPase assay. Purified intact myosin was phosphorylated to 1 mol/mol by GST-Rho-kinase, and then the actin-activated MgATPase activity was measured. The MgATPase activity of the phosphorylated myosin increased in a F-actin-dependent manner to the extent similar to that increased by MLC kinase (Fig. 3). The apparent Ka values for actin and the molecular activity of the phosphorylated myosin were 0.56 ± 0.05 µM and 0.18 ± 0.02 s-1, respectively. These values were roughly the same as those for the myosin phosphorylated by MLC kinase. We used GST-Rho-kinase instead of native Rho-kinase in this experiment because high concentrations of myosin were necessary to detect the myosin ATPase activity and the stoichiometrical phosphorylation of myosin by native Rho-kinase was difficult under the conditions.


Fig. 3. Effect of phosphorylation of myosin by Rho-kinase on the MgATPase activity that was activated by actin. Myosin was incubated with GST-Rho-kinase (black-square), with MLC kinase (black-diamond ), or without kinase (bullet ). After incubation, the ATPase activity was measured at the various concentrations of F-actin. The values shown are means ± S.E. of triplicates.
[View Larger Version of this Image (18K GIF file)]

We showed here that Rho-kinase phosphorylated both isolated MLC and MLC of intact myosin in a GTP·Rho-dependent manner. The primary phosphorylation site of MLC by Rho-kinase was at Ser-19, which is the same site phosphorylated by MLC kinase. The phosphorylation of MLC of intact myosin increased the MgATPase activity of myosin. These results indicate that Rho-kinase phosphorylates the MLC of intact myosin and activates its MgATPase activity in a GTP·Rho-dependent manner. The Km value of Rho-kinase for MLC was lower than that of MLC kinase, but the molecular activity of Rho-kinase was lower than that of MLC kinase. This indicates that Rho-kinase efficiently phosphorylates MLC at lower concentrations.

When smooth muscles are stimulated by an agonist such as vasoconstrictors, Ca2+ is mobilized into the cytoplasm. Ca2+ activates the calmodulin-dependent MLC kinase. Because smooth muscles contain large amounts of myosin (about 10% of the total protein, about 50 µM) and MLC kinase (about 0.1% of the total protein) (19), MLC kinase is believed to phosphorylate MLC in smooth muscles. However, non-muscle tissue such as liver contains much smaller amounts of myosin and MLC kinase (data not shown). Rho-kinase is ubiquitously expressed in various tissues (17). We have speculated that Rho-kinase phosphorylates the MLC of intact myosin and activates MgATPase in a GTP·Rho-dependent manner when non-muscle cells are stimulated by an agonist such as lysophosphatidic acid and certain growth factors and that the phosphorylated myosin interacts with actin leading to stress fiber and contractile ring formation (Fig. 4). In fact, we have recently found that overexpression of dominant activated RhoA (RhoAV14) in NIH3T3 cells results in an increase in MLC phosphorylation as well as stress fiber formation (16). This may be partly explained by the fact that GTP·RhoA interacts with Rho-kinase and MBS of myosin phosphatase and activates Rho-kinase; the activated Rho-kinase subsequently phosphorylates the MBS, thereby inactivating myosin phosphatase (Fig. 4) (16). We have assumed that phosphorylation of MLC by Rho-kinase also contributes to the increased level of MLC phosphorylation in these cells. Further studies are necessary to understand the roles of Rho-kinase in controlling MLC phosphorylation.


Fig. 4. Model for the regulation of MLC phosphorylation by Rho, Rho-kinase, and myosin phosphatase. Cat, catalytic subunit of myosin phosphatase.
[View Larger Version of this Image (22K GIF file)]


FOOTNOTES

*   This study was supported by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science, and Culture, Japan (1995) and by Mitsubishi Foundation (1995). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    To whom correspondence should be addressed. Tel.: 81-7437-2-5440; Fax: 81-7437-2-5449; E-mail: kaibuchi{at}bs.aist-nara.ac.jp.
1   The abbreviations used are: MBS, myosin-binding subunit; MLC, myosin light chain; GTPgamma S, guanosine 5'-(3-O-thio)-triphosphate; GST, glutathione S-transferase; DTT, dithiothreitol; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; PAGE, polyacrylamide gel electrophoresis.
2   A detailed analysis concerning recombinant Rho-kinase will be described elsewhere.

Acknowledgments

We are grateful to M. Nishimura for secretarial assistance. We also thank Dr. J. T. Stull (University of Texas Southwestern Medical Center) for providing us the anti-myosin antibody, Drs. K. Okawa and A. Iwamatsu (Kirin Brewery Co. Ltd.) for peptide sequencing, and Dr. M. Inagaki (Aichi Cancer Center Research Institute) for helpful discussions.


REFERENCES

  1. Nobes, C., Hall, A. (1994) Curr. Opin. Genet. Dev. 4, 77-81 [CrossRef][Medline] [Order article via Infotrieve]
  2. Takai, Y., Sasaki, T., Tanaka, K., Nakanishi, H. (1995) Trends Biochem. Sci. 20, 227-231 [CrossRef][Medline] [Order article via Infotrieve]
  3. Ridley, A. J., Hall, A. (1992) Cell 70, 389-399 [CrossRef][Medline] [Order article via Infotrieve]
  4. Ridley, A. J., Hall, A. (1994) EMBO J. 13, 2600-2610 [Medline] [Order article via Infotrieve]
  5. Paterson, H. F., Self, A. J., Garrett, M. D., Just, I., Aktories, K., Hall, A. (1990) J. Cell Biol. 111, 1001-1007 [Abstract/Free Full Text]
  6. Tominaga, T., Sugie, K., Hirata, M., Morii, N., Fukata, J., Uchida, A., Imura, H., Narumiya, S. (1993) J. Cell Biol. 120, 1529-1537 [Abstract/Free Full Text]
  7. Takaishi, K., Sasaki, T., Kato, M., Yamochi, W., Kuroda, S., Nakamura, T., Takeichi, M., Takai, Y. (1994) Oncogene 9, 273-279 [Medline] [Order article via Infotrieve]
  8. Kishi, K., Sasaki, T., Kuroda, S., Itoh, T., Takai, Y. (1993) J. Cell Biol. 120, 1187-1195 [Abstract/Free Full Text]
  9. Mabuchi, I., Hamaguchi, Y., Fujimoto, H., Morii, N., Mishima, M., Narumiya, S. (1993) Zygote 1, 325-331 [Medline] [Order article via Infotrieve]
  10. Zhang, J., King, W. G., Dillon, S., Hall, A., Feig, L., Rittenhouse, S. E. (1993) J. Biol. Chem. 268, 22251-22254 [Abstract/Free Full Text]
  11. Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y., Narumiya, S. (1993) J. Biol. Chem. 268, 24535-24538 [Abstract/Free Full Text]
  12. Zhang, J., Zhang, J., Benovic, J. L., Sugai, M., Wetzker, R., Gout, I., Rittenhouse, S. E. (1995) J. Biol. Chem. 270, 6589-6594 [Abstract/Free Full Text]
  13. Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., Schwartz, M. A. (1994) Cell 79, 507-513 [CrossRef][Medline] [Order article via Infotrieve]
  14. Hill, C. S., Wynne, J., Treisman, R. (1995) Cell 81, 1159-1170 [CrossRef][Medline] [Order article via Infotrieve]
  15. Amano, M., Mukai, H., Ono, Y., Chihara, K., Matsui, T., Hamajima, Y., Okawa, K., Iwamatsu, A., Kaibuchi, K. (1996) Science 271, 648-650 [Abstract]
  16. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A., Kaibuchi, K. (1996) Science 273, 245-248 [Abstract]
  17. Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., Kaibuchi, K. (1996) EMBO J. 15, 2208-2216 [Medline] [Order article via Infotrieve]
  18. Leung, T., Manser, E., Tan, L., Lim, L. (1995) J. Biol. Chem. 270, 29051-29054 [Abstract/Free Full Text]
  19. Kamm, K. E., Stull, J. T. (1985) Annu. Rev. Pharmacol. Toxicol. 25, 593-603 [CrossRef][Medline] [Order article via Infotrieve]
  20. Hartshorne, D. J., Johnson, D. R. (1987) Physiology of the Gastrointestinal Tract (Johnson, L. R., eds) , p. 423, Raven Press, New York
  21. Sellers, J. R., Adelstein, R. S. (1987) The Enzyme (Boyer, P., Erevs, E. G., eds) , Vol 18, p. 381, Academic Press, San Diego, CA
  22. Huttenlocher, A., Sandborg, R. R., Horwitz, A. (1995) Curr. Opin. Cell Biol. 7, 697-706 [CrossRef][Medline] [Order article via Infotrieve]
  23. Ikebe, M., Hartshorne, D. J. (1985) J. Biol. Chem. 260, 10027-10031 [Abstract/Free Full Text]
  24. Tan, J. L., Ravid, S., Spudich, J. A. (1992) Annu. Rev. Biochem. 61, 721-759 [CrossRef][Medline] [Order article via Infotrieve]
  25. Bradley, A. B., Morgan, K. G. (1987) J. Physiol. (Lond.) 385, 437-448 [Abstract/Free Full Text]
  26. Kitazawa, T., Masuo, M., Somlyo, A. P. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9307-9310 [Abstract/Free Full Text]
  27. Moreland, S., Nishimura, J., van Breeman, C., Ahn, H. Y., Moreland, R. S. (1992) Am. J. Physiol. 263, C540-C544 [Abstract/Free Full Text]
  28. Hirata, K., Kikuchi, A., Sasaki, T., Kuroda, S., Kaibuchi, K., Matsuura, Y., Seki, H., Saida, K., Takai, Y. (1992) J. Biol. Chem. 267, 8719-8722 [Abstract/Free Full Text]
  29. Noda, M., Yasuda-Fukazawa, C., Moriishi, K., Kato, T., Okuda, T., Kurokawa, K., Takuwa, Y. (1995) FEBS Lett. 367, 246-250 [CrossRef][Medline] [Order article via Infotrieve]
  30. Hathaway, D. R., Haeberle, J. R. (1983) Anal. Biochem. 135, 37-43 [CrossRef][Medline] [Order article via Infotrieve]
  31. Spudich, J. A., Watt, S. (1971) J. Biol. Chem. 246, 4866-4871 [Abstract/Free Full Text]
  32. Matsuura, Y., Possee, R. D., Overton, H. A., Bishop, D. H. L. (1987) J. Gen. Virol. 68, 1233-1250 [Abstract/Free Full Text]
  33. Ikebe, M., Barsotti, R. J., Hinkins, S., Hartshorne, D. J. (1984) Biochemistry 23, 5062-5068 [CrossRef][Medline] [Order article via Infotrieve]
  34. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  35. Naka, M., Nishikawa, M., Adelstein, R. S., Hidaka, H. (1983) Nature 306, 490-492 [CrossRef][Medline] [Order article via Infotrieve]
  36. Hunter, T., Sefton, B. M. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 1311-1315 [Abstract/Free Full Text]
  37. Satoh, T., Nakafuku, M., Kaziro, Y. (1992) J. Biol. Chem. 267, 24149-24152 [Free Full Text]
  38. McCormick, F. (1994) Curr. Opin. Genet. Dev. 4, 71-76 [CrossRef][Medline] [Order article via Infotrieve]
  39. Kamisoyama, H., Araki, Y., Ikebe, M. (1994) Biochemistry 33, 840-847 [CrossRef][Medline] [Order article via Infotrieve]
  40. Bresnick, A. R., Wolff-Long, V. L., Baumann, O., Pollard, T. D. (1995) Biochemistry 34, 12576-12583 [CrossRef][Medline] [Order article via Infotrieve]
  41. Nishikawa, M., Sellers, J. R., Adelstein, R. S., Hidaka, H. (1984) J. Biol. Chem. 259, 8808-8814 [Abstract/Free Full Text]
  42. Bengur, A. R., Robinson, E. A., Appella, E., Sellers, J. R. (1987) J. Biol. Chem. 262, 7613-7617 [Abstract/Free Full Text]
  43. Ikebe, M., Reardon, S. (1990) Biochemistry 29, 2713-2720 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
C. Beadle, M. C. Assanah, P. Monzo, R. Vallee, S. S. Rosenfeld, and P. Canoll
The Role of Myosin II in Glioma Invasion of the Brain
Mol. Biol. Cell, August 1, 2008; 19(8): 3357 - 3368.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Schramp, O. Ying, T. Y. Kim, and G. S. Martin
ERK5 promotes Src-induced podosome formation by limiting Rho activation
J. Cell Biol., June 30, 2008; 181(7): 1195 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H.-H. Lee and Z.-F. Chang
Regulation of RhoA-dependent ROCKII activation by Shp2
J. Cell Biol., June 16, 2008; 181(6): 999 - 1012.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Wasylnka, M. A. Bakowski, J. Szeto, M. B. Ohlson, W. S. Trimble, S. I. Miller, and J. H. Brumell
Role for Myosin II in Regulating Positioning of Salmonella-Containing Vacuoles and Intracellular Replication
Infect. Immun., June 1, 2008; 76(6): 2722 - 2735.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Hanazaki, M. Yokoyama, K. Morita, A. Kohjitani, H. Sakai, Y. Chiba, and M. Misawa
Rho-Kinase Inhibitors Augment the Inhibitory Effect of Propofol on Rat Bronchial Smooth Muscle Contraction
Anesth. Analg., June 1, 2008; 106(6): 1765 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Deng, P. F. Mercer, C. J. Scotton, A. Gilchrist, and R. C. Chambers
Thrombin Induces Fibroblast CCL2/JE Production and Release via Coupling of PAR1 to G{alpha}q and Cooperation between ERK1/2 and Rho Kinase Signaling Pathways
Mol. Biol. Cell, June 1, 2008; 19(6): 2520 - 2533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Nagamatsu, Y. Rikitake, M. Takahashi, Y. Deki, W. Ikeda, K.-i. Hirata, and Y. Takai
Roles of Necl-5/Poliovirus Receptor and Rho-associated Kinase (ROCK) in the Regulation of Transformation of Integrin {alpha}V{beta}3-based Focal Complexes into Focal Adhesions
J. Biol. Chem., May 23, 2008; 283(21): 14532 - 14541.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Solinet and M. L. Vitale
Isoform B of myosin II heavy chain mediates actomyosin contractility during TNF{alpha}-induced apoptosis
J. Cell Sci., May 15, 2008; 121(10): 1681 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Mulinari, M. P. Barmchi, and U. Hacker
DRhoGEF2 and Diaphanous Regulate Contractile Force during Segmental Groove Morphogenesis in the Drosophila Embryo
Mol. Biol. Cell, May 1, 2008; 19(5): 1883 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y.-C. Chang, P. Nalbant, J. Birkenfeld, Z.-F. Chang, and G. M. Bokoch
GEF-H1 Couples Nocodazole-induced Microtubule Disassembly to Cell Contractility via RhoA
Mol. Biol. Cell, May 1, 2008; 19(5): 2147 - 2153.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Nishimura and M. Takeichi
Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling
Development, April 15, 2008; 135(8): 1493 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. D. Chilcoat, Y. Sharief, and S. L. Jones
Tonic protein kinase A activity maintains inactive {beta}2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase
J. Leukoc. Biol., April 1, 2008; 83(4): 964 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. F. G. van Helden, M. M. Oud, B. Joosten, N. Peterse, C. G. Figdor, and F. N. van Leeuwen
PGE2-mediated podosome loss in dendritic cells is dependent on actomyosin contraction downstream of the RhoA-Rho-kinase axis
J. Cell Sci., April 1, 2008; 121(7): 1096 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. R. S. Broughton, B. R. Walker, and T. C. Resta
Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L797 - L806.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
H. Tanihara, M. Inatani, M. Honjo, H. Tokushige, J. Azuma, and M. Araie
Intraocular Pressure-Lowering Effects and Safety of Topical Administration of a Selective ROCK Inhibitor, SNJ-1656, in Healthy Volunteers
Arch Ophthalmol, March 1, 2008; 126(3): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. N. Hamadmad and R. J. Hohl
Erythropoietin Stimulates Cancer Cell Migration and Activates RhoA Protein through a Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase-Dependent Mechanism
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1227 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Umeda, S. Yano, K. Yamada, and H. Tachibana
Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor
J. Biol. Chem., February 8, 2008; 283(6): 3050 - 3058.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. T. Mierke, P. Kollmannsberger, D. Paranhos Zitterbart, J. Smith, B. Fabry, and W. H. Goldmann
Mechano-Coupling and Regulation of Contractility by the Vinculin Tail Domain
Biophys. J., January 15, 2008; 94(2): 661 - 670.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. A. Conti and R. S. Adelstein
Nonmuscle myosin II moves in new directions
J. Cell Sci., January 1, 2008; 121(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Y. Mong, C. Petrulio, H. L. Kaufman, and Q. Wang
Activation of Rho Kinase by TNF-{alpha} Is Required for JNK Activation in Human Pulmonary Microvascular Endothelial Cells
J. Immunol., January 1, 2008; 180(1): 550 - 558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Kanada, A. Nagasaki, and T. Q.P. Uyeda
Novel Functions of Ect2 in Polar Lamellipodia Formation and Polarity Maintenance during "Contractile Ring-Independent" Cytokinesis in Adherent Cells
Mol. Biol. Cell, January 1, 2008; 19(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. Dyer, E. Rebollo, P. Dominguez, N. Elkhatib, P. Chavrier, L. Daviet, C. Gonzalez, and M. Gonzalez-Gaitan
Spermatocyte cytokinesis requires rapid membrane addition mediated by ARF6 on central spindle recycling endosomes
Development, December 15, 2007; 134(24): 4437 - 4447.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Boettner and L. Van Aelst
The Rap GTPase Activator Drosophila PDZ-GEF Regulates Cell Shape in Epithelial Migration and Morphogenesis
Mol. Cell. Biol., November 15, 2007; 27(22): 7966 - 7980.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
P. Flevaris, A. Stojanovic, H. Gong, A. Chishti, E. Welch, and X. Du
A molecular switch that controls cell spreading and retraction
J. Cell Biol., November 5, 2007; 179(3): 553 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Waiczies, I. Bendix, T. Prozorovski, M. Ratner, I. Nazarenko, C. F. Pfueller, A. U. Brandt, J. Herz, S. Brocke, O. Ullrich, et al.
Geranylgeranylation but Not GTP Loading Determines Rho Migratory Function in T Cells
J. Immunol., November 1, 2007; 179(9): 6024 - 6032.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Takizawa, R. Ikebe, M. Ikebe, and E. J. Luna
Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery
J. Cell Sci., November 1, 2007; 120(21): 3792 - 3803.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. S. Dhaliwal, D. B. Casey, A. J. Greco, A. M. Badejo Jr., T. B. Gallen, S. N. Murthy, B. D. Nossaman, A. L. Hyman, and P. J. Kadowitz
Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1306 - L1313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. J. Allahdadi, B. R. Walker, and N. L. Kanagy
ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2911 - H2918.
[Abstract] [Full Text] [PDF]